Amantadine

spinqualitylabelsall models Amantadine, also known as Symmetrel (2kqt) Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D Better Known as: Symmetrel Marketed By: Endo Pharmaceuticals Major Indication: Influenza Infection Drug Class: M2 Proton Channel Inhibitor Date of FDA Approval (Patent Expiration): 1966 (1986) 1994 Sales: N/A Importance: One of the the first treatments approved by the FDA and the first approved for treatment of Influenza Infections. Nearly 100% of influenza viruses had developed resistance to rimantadine, and it is no longer recommended as a treatment for the flu. Interestingly, in 1969 it was also discovered that Amantadine helped reduce the symptoms of Parkinson's Disease. See Pharmaceutical Drugs for more information about other drugs and disorders. (Restore initial scene). Mechanism of Action The Influenza A Virus viral envelope is dotted with various ion channels including M2 Proton Channels. The M2 protein plays a critical role in the life cycle of the Influenza virus. It enables hydrogen ions to enter the virion form the endosome. The result of this is a more acidic environment within the virus, causing dissociation of the viral matrix protein M1 from the ribonucleoprotein RNP. Dissociation of the viral matrix protein is a crucial step in uncoating of the virus and exposing its contents to the cytoplasm of the host cell, allowing the virus to hijack the cellular machinery to replicate. Amantadine binds to the pore formed by the M2 protein, utilizing Val 27, Ala 30 and Ser 31 in each M2 protein chain, effectively disabling the protein from transferring protons into the viral particle.

Pharmacokinetics

M2 Proton Channel Inhibitor Influenza Parameter M2 Proton Channel Amantadine Influenza (hr) 4.3 2.5 Pharmaceutical Drugs (ng/ml) 310 402 Influenza (%) >90 >90 ion channels (%) 40 67 M2 Proton Channels (hr) 27.7 ~15 AUC (ng/ml/hr) 11917 5420 Dosage (mg) 100 100 Metabolism Negligible Negligible For Pharmacokinetic Data References, See: References

Proteopedia Page Contributors and Editors (what is this?)

David Canner, Eric Martz, Alexander Berchansky